Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor

International Journal of Pharmaceutics

Volumn 488, Issue 1-2, 2015, Pages 44-58

  Chen, Yanzuo ^a,b   Zhang, Wei ^b,c   Huang, Yukun ^a   Gao, Feng ^a   Sha, Xianyi ^b   Fang, Xiaoling ^b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Anti cancer efficacy; Codelivery; Doxorubicin; Multidrug resistance; Paclitaxel; Polymeric micelle

Indexed keywords

DOXORUBICIN; PACLITAXEL; POLOXAMER; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; MICELLE; PLURONIC P105;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL CYCLE ARREST; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MALE; MICELLE; MOUSE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUMOR; NEOPLASM; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; MEDICINAL CHEMISTRY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICELLES; PACLITAXEL; POLOXAMER;

EID: 84928471970     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.04.048     Document Type: Article

References (56)

1. S. AbuHammad, and M. Zihlif Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line Genomics 101 2013 213 220
2. F. Ahmed, R.I. Pakunlu, A. Brannan, F. Bates, T. Minko, and D.E. Discher Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug J. Controlled Release 116 2006 150 158
3. E.V. Batrakova, D.L. Kelly, S. Li, Y. Li, Z. Yang, L. Xiao, D.Y. Alakhova, S. Sherman, V.Y. Alakhov, and A.V. Kabanov Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: Pluronic P85 Mol. Pharm. 3 2005 113 123
4. W. Berger, U. Setinek, P. Hollaus, T. Zidek, E. Steiner, L. Elbling, H. Cantonati, J. Attems, A. Gsur, and M. Micksche Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications J. Cancer Res. Clin. Oncol. 131 2005 355 363
5. H. Cabral, and K. Kataoka Progress of drug-loaded polymeric micelles into clinical studies J. Controlled Release 190 2014 465 476
6. M. Calderon, R. Graeser, F. Kratz, and R. Haag Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol Bioorg. Med. Chem. Lett. 19 2009 3725 3728
7. L. Chen, X. Sha, X. Jiang, Y. Chen, Q. Ren, and X. Fang Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation Int. J. Nanomed. 8 2013 73 84
8. Y. Chen, X. Sha, W. Zhang, W. Zhong, Z. Fan, Q. Ren, L. Chen, and X. Fang Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation Int. J. Nanomed. 8 2013 1463 1476
9. Y. Chen, W. Yang, B. Chang, H. Hu, X. Fang, and X. Sha In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation Eur. J. Pharm. Biopharm. 85 2013 406 412
10. Y. Chen, W. Zhang, J. Gu, Q. Ren, Z. Fan, W. Zhong, X. Fang, and X. Sha Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer Int. J. Pharm. 452 2013 421 433
11. C.D. Davies, H. Muller, I. Hagen, M. Garseth, and M.H. Hjelstuen Comparison of extracellular matrix in human osteosarcomas and melanomas growing as xenografts, multicellular spheroids, and monolayer cultures Anticancer Res. 17 1997 4317 4326
12. J.P. de Hoon, J. Veeck, B.E. Vriens, T.G. Calon, M. van Engeland, and V.C. Tjan-Heijnen Taxane resistance in breast cancer: a closed HER2 circuit? Biochim. Biophys. Acta 1825 2012 197 206
13. C. Deng, Y. Jiang, R. Cheng, F. Meng, and Z. Zhong Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects Nano Today 7 2012 467 480
14. J.L. Eiseman, N.D. Eddington, J. Leslie, C. MacAuley, D.L. Sentz, M. Zuhowski, J.M. Kujawa, D. Young, and M.J. Egorin Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice Cancer Chemother. Pharmacol. 34 1994 465 471
15. T. Feng, H. Tian, C. Xu, L. Lin, Z. Xie, M.H. Lam, H. Liang, and X. Chen Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment Eur. J. Pharm. Biopharm. 2014 1086 1093
16. A.L. Ferreira, L.S. Matsubara, and B.B. Matsubara Anthracycline-induced cardiotoxicity Cardiovasc. Hematol. Agents Med. Chem. 6 2008 278 281
17. D.A. Gewirtz A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin Biochem. Pharmacol. 57 1999 727 741
18. D.L. Gustafson, A.L. Merz, and M.E. Long Pharmacokinetics of combined doxorubicin and paclitaxel in mice Cancer Lett. 220 2005 161 169
19. C.F. Higgins Multiple molecular mechanisms for multidrug resistance transporters Nature 446 2007 749 757
20. H.A. Hirsch, D. Iliopoulos, P.N. Tsichlis, and K. Struhl Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission Cancer Res. 69 2009 7507 7511
21. Y. Huang, K.R. Johnson, J.S. Norris, and W. Fan Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells Cancer Res. 60 2000 4426 4432
22. R. Ippoliti, P. Ginobbi, E. Lendaro, I. D'Agostino, D. Ombres, P.A. Benedetti, M. Brunori, and G. Citro The effect of monensin and chloroquine on the endocytosis and toxicity of chimeric toxins Cell. Mol. Life Sci. 54 1998 866 875
23. R.K. Jain Delivery of molecular and cellular medicine to solid tumors Adv. Drug Deliv. Rev. 64 2012 353 365
24. X. Jiang, X. Sha, H. Xin, X. Xu, J. Gu, W. Xia, S. Chen, Y. Xie, L. Chen, Y. Chen, and X. Fang Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel Biomaterials 34 2013 2969 2979
25. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov Pluronic block copolymers for overcoming drug resistance in cancer Adv. Drug Deliv. Rev. 54 2002 759 779
26. W.G. Kaelin Jr. The concept of synthetic lethality in the context of anticancer therapy Nat. Rev. Cancer 5 2005 689 698
27. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 64 2012 37 48
28. D. Kim, E.S. Lee, K. Park, I.C. Kwon, and Y.H. Bae Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor Pharm. Res. 25 2008 2074 2082
29. K. Kostarelos, D. Emfietzoglou, A. Papakostas, W.H. Yang, A. Ballangrud, and G. Sgouros Binding and interstitial penetration of liposomes within avascular tumor spheroids Int. J. Cancer 112 2004 713 721
30. S. Lee, M. Baek, H.-Y. Kim, J.-H. Ha, and D.-I. Jeoung Mechanism of doxorubicin-induced cell death and expression profile analysis Biotechnol. Lett. 24 2002 1147 1151
31. J. Lehar, A.S. Krueger, W. Avery, A.M. Heilbut, L.M. Johansen, E.R. Price, R.J. Rickles, G.F. Short 3rd, J.E. Staunton, X. Jin, M.S. Lee, G.R. Zimmermann, and A.A. Borisy Synergistic drug combinations tend to improve therapeutically relevant selectivity Nat. Biotechnol. 27 2009 659 666
32. B.S. Lele, and M.G. Kulkarni Single step room temperature oxidation of poly(ethylene glycol) to poly(oxyethylene)-dicarboxylic acid J. Appl. Polym. Sci. 70 1998 883 890
33. J. Liu, and J.I. Shapiro Endocytosis and signal transduction: basic science update Biol. Res. Nurs. 5 2003 117 128
34. Y. Liu, L. Huang, and F. Liu Paclitaxel nanocrystals for overcoming multidrug resistance in cancer Mol. Pharm. 7 2010 863 869
35. W. Loscher, and H. Potschka Drug resistance in brain diseases and the role of drug efflux transporters Nat. Rev. Neurosci. 6 2005 591 602
36. Y. Ma, D. Liu, D. Wang, Y. Wang, Q. Fu, J.K. Fallon, X. Yang, Z. He, and F. Liu Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer Mol. Pharm. 11 2014 2623 2630
37. A.I. Minchinton, and I.F. Tannock Drug penetration in solid tumours Nat. Rev. Cancer 6 2006 583 592
38. G. Misinzo, P.L. Delputte, and H.J. Nauwynck Inhibition of endosome-lysosome system acidification enhances porcine circovirus 2 infection of porcine epithelial cells J. Virol. 82 2008 1128 1135
39. L.Y. Qiu, and Y.H. Bae Polymer architecture and drug delivery Pharm. Res. 23 2006 1 30
40. V. Saxena, and M.D. Hussain Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer Int. J. Nanomed. 7 2012 713 721
41. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
42. N.K. Swarnakar, K. Thanki, and S. Jain Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin- and Coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin Nanomedicine 10 2014 1231 1241
43. R.J. Tallarida Drug synergism: its detection and applications J. Pharmacol. Exp. Ther. 298 2001 865 872
44. V.P. Torchilin Structure and design of polymeric surfactant-based drug delivery systems J. Controlled Release 73 2001 137 172
45. T.A. Ulrich, A. Jain, K. Tanner, J.L. MacKay, and S. Kumar Probing cellular mechanobiology in three-dimensional culture with collagen-agarose matrices Biomaterials 31 2010 1875 1884
46. H. Wang, Y. Zhao, Y. Wu, Y.L. Hu, K. Nan, G. Nie, and H. Chen Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles Biomaterials 32 2011 8281 8290
47. Y. Wang, J. Hao, Y. Li, Z. Zhang, X. Sha, L. Han, and X. Fang Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors Biomaterials 33 2012 4741 4751
48. Y. Wang, L. Yu, L. Han, X. Sha, and X. Fang Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines Int. J. Pharm. 337 2007 63 73
49. Z. Wei, J. Hao, S. Yuan, Y. Li, W. Juan, X. Sha, and X. Fang Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization Int. J. Pharm. 376 2009 176 185
50. B. Weisblum, and E. Haenssler Fluorometric properties of the bibenzimidazole derivative Hoechst 33258, a fluorescent probe specific for AT concentration in chromosomal DNA Chromosoma 46 1974 255 260
51. X.-B. Xiong, Z. Ma, R. Lai, and A. Lavasanifar The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin Biomaterials 31 2010 757 768
52. H.J. Yao, R.J. Ju, X.X. Wang, Y. Zhang, R.J. Li, Y. Yu, L. Zhang, and W.L. Lu The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery Biomaterials 32 2011 3285 3302
53. W. Zhang, Y. Shi, Y. Chen, J. Hao, X. Sha, and X. Fang The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models Biomaterials 32 2011 5934 5944
54. W. Zhang, Y. Shi, Y. Chen, J. Ye, X. Sha, and X. Fang Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors Biomaterials 32 2011 2894 2906
55. W. Zhang, Y. Shi, Y. Chen, S. Yu, J. Hao, J. Luo, X. Sha, and X. Fang Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance Eur. J. Pharm. Biopharm. 75 2010 341 353
56. Y.Z. Zhao, C.Z. Sun, C.T. Lu, D.D. Dai, H.F. Lv, Y. Wu, C.W. Wan, L.J. Chen, M. Lin, and X.K. Li Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro Cancer Lett. 311 2011 187 194